Cianna debuts ScoutCare program

Brachytherapy firm Cianna Medical is launching its ScoutCare support program...Read more on AuntMinnie.comRelated Reading: Cianna touts Scout research Cianna nets FDA OK for radar system Cianna highlights SAVI Scout results at SBI Cianna advances 2 SAVI Scout studies Cianna nets FDA OK for SAVI Scout
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news

Related Links:

To the Editor: We read with interest the article by Valdes et  al in which machine learning methods were used to predict biochemical failure after salvage brachytherapy for prostate cancer (1). Although the article addresses a relevant clinical issue, we are concerned that there are issues with the statistical methods that undermine the conclusion of good pre dictive performance. Given the many recent papers in our field applying machine learning to clinical questions, the themes discussed in this letter may apply more broadly.
Source: International Journal of Radiation Oncology * Biology * Physics - Category: Radiology Authors: Tags: Comment Source Type: research
To the Editor: We would like to thank the authors for their comments on our work and for raising general points regarding statistics and machine learning that are important for public discussion (1). It was partly with the intention of generating these types of discussions that we wrote our paper, “Salvage HDR Brachytherapy: Multiple Hypothesis Testing Versus Machine Learning Analysis (2).” As such, we would like to thank the editor for giving us the opportunity to reply. We believe that our revised article, with the comments and our response, offers a better picture of the applications o f machine learning to ...
Source: International Journal of Radiation Oncology * Biology * Physics - Category: Radiology Authors: Tags: Comment Source Type: research
To the Editor: The work of Bauer-Nilsen et  al explores time-driven activity-based cost (TDABC) and reimbursement of cervical cancer radiation therapy (1). The authors propose that high TDABC but low reimbursement could contribute to the declining use of brachytherapy. Overall, the analysis was intriguing and generated discussion among the American Society for Radiation Oncology's Code Development and Valuation Sub-Committee, which analyzes reimbursement for radiation oncology services. Although TDABC may be useful in better understanding practice cost drivers, there are limitations in the analysis that prevent genera...
Source: International Journal of Radiation Oncology * Biology * Physics - Category: Radiology Authors: Tags: Comment Source Type: research
To the Editor: I appreciate the comments of Orio and Goodwin and agree that a single-institution study using our research methodology is not the appropriate method for calculations to inform Centers for Medicare and Medicaid Services payment determinations (1). Instead, our priority was to compare the physician effort and relative radiation oncology physician reimbursement for the brachytherapy versus external beam radiation therapy components of the course. I agree that substantial overhead costs and different health care environments must be considered when estimating an appropriate payment policy.
Source: International Journal of Radiation Oncology * Biology * Physics - Category: Radiology Authors: Tags: Comment Source Type: research
DiscussionChronic inflammation can promote cell proliferation and growth. The use of immunomodulatory drugs is associated with an increased risk of developing melanoma and non-melanoma skin cancer. The two patients described in this report both had long-standing IBD treated with immunomodulatory drugs. It seems reasonable to suggest that these two factors may have promoted the development of uveal melanoma. More studies are warranted to investigate and confirm this possible association.
Source: Reports of Practical Oncology and Radiotherapy - Category: Cancer & Oncology Source Type: research
IMRT and 3D image-guided adapted brachytherapy (3D-IGABT) is increasingly used for definitive cervical cancer treatment. We compared patterns of failure and survival to patients treated with 2D external beam radiation and brachytherapy, with all patients receiving a pre-treatment PET and all surviving patients having 5 years minimum follow up. IMRT and 3D-IGABT was associated with higher survival and reduced late bowel and bladder toxicities.
Source: International Journal of Radiation Oncology * Biology * Physics - Category: Radiology Authors: Tags: Clinical Investigation Source Type: research
It has been reported that proximity of the tumor to the optic disc and macula, and radiation dose to the critical structures are substantial risk factors for vision loss following plaque brachytherapy. However...
Source: Radiation Oncology - Category: Cancer & Oncology Authors: Tags: Research Source Type: research
Publication date: Available online 10 November 2018Source: European UrologyAuthor(s): Sebastian Berg, Alexander P. Cole, Marieke J. Krimphove, Junaid Nabi, Maya Marchese, Stuart R. Lipsitz, Joachim Noldus, Toni K. Choueiri, Adam S. Kibel, Quoc-Dien TrinhAbstractA previous study comparing external beam radiation therapy with/without brachytherapy (EBRT ± BT) and radical prostatectomy (RP) for high-risk localized prostate cancer (PCa) did not find a difference in overall survival (OS) between the treatments. However, this study was limited by short follow-up and assessment of OS in patients of divergent age ...
Source: European Urology - Category: Urology & Nephrology Source Type: research
CONCLUSION: LDR brachytherapy is a highly effective low-impact treatment option for New Zealand men with early stage prostate cancer. PMID: 30408814 [PubMed - in process]
Source: New Zealand Medical Journal - Category: General Medicine Tags: N Z Med J Source Type: research
Hypnosedation (HS) for brachytherapy has been proposed in patients with prostate cancer and has been evaluated.
Source: Brachytherapy - Category: Cancer & Oncology Authors: Source Type: research
More News: Brachytherapy | Study